• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

138 例外阴硬化性苔藓患者研究及恶变风险转化。

Study of 138 vulvar lichen sclerosus patients and the malignant risk transformation.

机构信息

Universidade Federal Fluminense NiteróiRJ Brazil Universidade Federal Fluminense, Niterói, RJ, Brazil.

Universidade Federal do Paraná CuritibaPR Brazil Universidade Federal do Paraná, Curitiba, PR, Brazil.

出版信息

Rev Bras Ginecol Obstet. 2024 Jul 26;46. doi: 10.61622/rbgo/2024rbgo62. eCollection 2024.

DOI:10.61622/rbgo/2024rbgo62
PMID:39176197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11341183/
Abstract

OBJECTIVE

To report the prevalence of malignant transformation of vulvar lichen sclerosus (VLS) and possible risk factors.

METHODS

This is a cohort study with data analysis from medical records of 138 patients with histological diagnosis of VLS registered at the Vulvar Pathology Outpatient Clinic of the University Hospital, between 2007 and 2017. Predominance of risk factors was performed using logistic regression analysis. The variables studied were the length of follow-up, age, regular or irregular follow up; presence of symptoms (dyspareunia, pruritus and/or vulvar burning); histology characteristics, the presence of epithelial hyperplasia; and the presence of autoimmune diseases.

RESULTS

There were 138 patients included in the study, and among them five progressed to malignant transformation. The patients had a median age of 59 years and 83% were symptomatic. The most frequent symptom was itching with 72%. Autoimmune diseases were present in 11.6%, the most prevalent being thyroid disease. All five case of malignant transformation (0.6%) had an irregular follow up. The logistic regression analysis was used among the studied variables, and no statistical significance was found among them (p ≥ 0.05). The relationship between hyperplasia and the clinical outcome of malignant transformation, in which non-significant but acceptable p value close to 0.05 was observed.

CONCLUSION

The prevalence of malignant transformation in patients with VLS was 0.6%, and common factors were the lack of adherence to medical treatments and the loss of follow-up.

摘要

目的

报告外阴硬化性苔藓(VLS)恶变的发生率及可能的危险因素。

方法

这是一项队列研究,对 2007 年至 2017 年间在大学医院外阴病理门诊登记的 138 例组织学诊断为 VLS 的患者的病历进行数据分析。使用逻辑回归分析来评估危险因素的优势。研究的变量包括随访时间、年龄、定期或不定期随访、症状(性交困难、瘙痒和/或外阴烧灼感)、组织学特征(上皮增生)、自身免疫性疾病。

结果

本研究共纳入 138 例患者,其中 5 例发生恶变。患者的中位年龄为 59 岁,83%有症状。最常见的症状是瘙痒,占 72%。自身免疫性疾病的发生率为 11.6%,最常见的是甲状腺疾病。所有 5 例恶变病例(0.6%)均未定期随访。对研究变量进行逻辑回归分析,未发现统计学意义(p≥0.05)。在增生与恶性转化的临床结局之间存在一定的关系,但观察到的 p 值接近 0.05,无统计学意义。

结论

VLS 患者恶变的发生率为 0.6%,常见的因素是不遵医嘱和失去随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/11341183/d7912f0a6f95/1806-9339-rbgo-46-e-rbgo62-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/11341183/cf61d8b617ff/1806-9339-rbgo-46-e-rbgo62-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/11341183/d7912f0a6f95/1806-9339-rbgo-46-e-rbgo62-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/11341183/cf61d8b617ff/1806-9339-rbgo-46-e-rbgo62-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9e/11341183/d7912f0a6f95/1806-9339-rbgo-46-e-rbgo62-gf02.jpg

相似文献

1
Study of 138 vulvar lichen sclerosus patients and the malignant risk transformation.138 例外阴硬化性苔藓患者研究及恶变风险转化。
Rev Bras Ginecol Obstet. 2024 Jul 26;46. doi: 10.61622/rbgo/2024rbgo62. eCollection 2024.
2
Vulvar Lichen Sclerosus and Neoplastic Transformation: A Retrospective Study of 976 Cases.外阴硬化性苔藓与肿瘤转化:976例回顾性研究
J Low Genit Tract Dis. 2016 Apr;20(2):180-3. doi: 10.1097/LGT.0000000000000186.
3
Differential proteomic expression in indolent vulvar lichen sclerosus, transforming vulvar lichen sclerosus and normal vulvar tissue.良性外阴硬化性苔藓、转化性外阴硬化性苔藓和正常外阴组织中的差异蛋白质组表达。
Exp Dermatol. 2022 Dec;31(12):1920-1926. doi: 10.1111/exd.14660. Epub 2022 Aug 26.
4
Vulvar lichen sclerosus: A single-center retrospective study in China.外阴硬化性苔藓:中国单中心回顾性研究。
J Dermatol. 2018 Sep;45(9):1101-1104. doi: 10.1111/1346-8138.14533. Epub 2018 Jul 9.
5
[Clinical and pathological analysis of 345 cases of vulvar lichen sclerosus and a preliminary study on the frequency of maintenance treatment].345例外阴硬化性苔藓的临床病理分析及维持治疗频率的初步研究
Zhonghua Fu Chan Ke Za Zhi. 2024 Jan 25;59(1):56-63. doi: 10.3760/cma.j.cn112141-20230909-00094.
6
Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review.外阴硬化性苔藓或扁平苔藓妇女发生外阴癌的风险:系统评价。
J Low Genit Tract Dis. 2022 Jul 1;26(3):250-257. doi: 10.1097/LGT.0000000000000673. Epub 2022 Mar 11.
7
Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women.成人外阴硬化性苔藓的长期管理:507 例女性前瞻性队列研究。
JAMA Dermatol. 2015 Oct;151(10):1061-7. doi: 10.1001/jamadermatol.2015.0643.
8
Characterization of patients with vulvar lichen sclerosus and association to vulvar carcinoma: a retrospective single center analysis.外阴硬化性苔藓患者的特征及其与外阴癌的关系:回顾性单中心分析。
Arch Gynecol Obstet. 2023 Jun;307(6):1921-1928. doi: 10.1007/s00404-022-06848-y. Epub 2022 Nov 21.
9
Protein markers of malignant potential in penile and vulvar lichen sclerosus.阴茎和外阴硬化性苔藓中恶性潜能的蛋白标志物。
J Urol. 2013 Aug;190(2):399-406. doi: 10.1016/j.juro.2013.01.102. Epub 2013 Feb 8.
10
The prevalence of self-reported medical comorbidities in patients with vulvar lichen sclerosus: A single-center retrospective study.外阴硬化性苔藓患者自报的合并症患病率:一项单中心回顾性研究。
Int J Gynaecol Obstet. 2021 May;153(2):340-343. doi: 10.1002/ijgo.13480. Epub 2020 Dec 12.

本文引用的文献

1
Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review.外阴硬化性苔藓或扁平苔藓妇女发生外阴癌的风险:系统评价。
J Low Genit Tract Dis. 2022 Jul 1;26(3):250-257. doi: 10.1097/LGT.0000000000000673. Epub 2022 Mar 11.
2
Risk of Vulvar Squamous Cell Carcinoma in Lichen Sclerosus and Lichen Planus: A Systematic Review.硬化性苔藓和扁平苔藓中外阴鳞状细胞癌的风险:一项系统评价
J Obstet Gynaecol Can. 2022 Feb;44(2):182-192. doi: 10.1016/j.jogc.2021.09.023. Epub 2021 Oct 19.
3
Diagnostic Criteria for Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation.
外阴上皮内瘤变和外阴异常成熟的诊断标准。
J Low Genit Tract Dis. 2021 Jan 1;25(1):57-70. doi: 10.1097/LGT.0000000000000572.
4
Etiology, Clinical Features, and Diagnosis of Vulvar Lichen Sclerosus: A Scoping Review.外阴硬化性苔藓的病因、临床特征及诊断:一项范围综述
Obstet Gynecol Int. 2020 Apr 21;2020:7480754. doi: 10.1155/2020/7480754. eCollection 2020.
5
The risk of developing squamous cell carcinoma in patients with anogenital lichen sclerosis: A systematic review.肛门生殖器硬化性苔藓患者发生鳞状细胞癌的风险:系统评价。
Gynecol Oncol. 2020 Jun;157(3):671-677. doi: 10.1016/j.ygyno.2020.02.020. Epub 2020 Feb 20.
6
Incidence of lichen sclerosus and subsequent causes of death: a nationwide Finnish register study.局限性硬皮病的发病率和后续死因:一项全国性的芬兰登记研究。
BJOG. 2020 Jun;127(7):814-819. doi: 10.1111/1471-0528.16175. Epub 2020 Mar 9.
7
Differentiated vulvar intraepithelial neoplasia (dVIN): the most helpful histological features and the utility of cytokeratins 13 and 17.分化型外阴上皮内瘤变(dVIN):最有帮助的组织学特征和细胞角蛋白 13 和 17 的应用。
Virchows Arch. 2018 Dec;473(6):739-747. doi: 10.1007/s00428-018-2436-8. Epub 2018 Sep 6.
8
Diagnosis and Treatment of Vulvar Lichen Sclerosus: An Update for Dermatologists.外阴硬化性苔藓的诊断与治疗:皮肤科医生的最新观点。
Am J Clin Dermatol. 2018 Oct;19(5):695-706. doi: 10.1007/s40257-018-0364-7.
9
Diagnosis and Treatment of Vulvar Dermatoses.外阴皮肤病的诊断与治疗。
Obstet Gynecol. 2018 Feb;131(2):371-386. doi: 10.1097/AOG.0000000000002460.
10
Lichen sclerosus in women: a review.女性硬化性苔藓:综述。
Climacteric. 2017 Aug;20(4):339-347. doi: 10.1080/13697137.2017.1343295. Epub 2017 Jun 29.